Mucosal mRNA-sLNP boosting following BCG vaccination induces local pulmonary immunity with limited inflammation
Year: 2026
Type: preprint
Abstract: Pulmonary vaccination improves protection against tuberculosis by generating immune responses at the primary site of Mycobacterium tuberculosis infection. However, pulmonary delivery of live vaccines can induce excessive inflammation and raises safety concerns. Here, we developed an mRNA-based prime-and-pull strategy in which subcutaneous BCG vaccination was followed by pulmonary delivery of mRNA formulated in stealth lipid nanoparticles. Pulmonary mRNA delivery supported protein expression in multiple lung cell populations. Using ESAT-6 as a model antigen, pulmonary mRNA boosting enhanced antigen-specific and memory T cell responses beyond those induced by mRNA alone. A multivalent mRNA formulation encoding eight selected M. tuberculosis - and BCG-derived antigens induced pulmonary T cell responses comparable to subcutaneous BCG vaccination, increased antibody reactivity, and increased stem cell-like memory T cell frequencies. Prime-and-pull vaccination reduced pulmonary inflammation and pathology relative to pulmonary BCG vaccination while maintaining protection comparable to subcutaneous BCG.
Source: Research Square
Institution: James Cook University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7171069350
